- Home
- MRIN vs ONVO Comparison
MRIN vs ONVO Comparison
Compare MRIN & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRIN
- ONVO
- Stock Information
- Founded
- MRIN 2006
- ONVO 2007
- Country
- MRIN United States
- ONVO United States
- Employees
- MRIN N/A
- ONVO N/A
- Industry
- MRIN EDP Services
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MRIN Technology
- ONVO Health Care
- Exchange
- MRIN Nasdaq
- ONVO Nasdaq
- Market Cap
- MRIN 6.4M
- ONVO 6.7M
- IPO Year
- MRIN 2013
- ONVO N/A
- Fundamental
- Price
- MRIN $2.03
- ONVO $0.34
- Analyst Decision
- MRIN
- ONVO
- Analyst Count
- MRIN 0
- ONVO 0
- Target Price
- MRIN N/A
- ONVO N/A
- AVG Volume (30 Days)
- MRIN 34.5K
- ONVO 250.2K
- Earning Date
- MRIN 02-20-2025
- ONVO 02-06-2025
- Dividend Yield
- MRIN N/A
- ONVO N/A
- EPS Growth
- MRIN N/A
- ONVO N/A
- EPS
- MRIN N/A
- ONVO N/A
- Revenue
- MRIN $16,707,999.00
- ONVO $103,000.00
- Revenue This Year
- MRIN N/A
- ONVO $59.08
- Revenue Next Year
- MRIN N/A
- ONVO $18.24
- P/E Ratio
- MRIN N/A
- ONVO N/A
- Revenue Growth
- MRIN N/A
- ONVO N/A
- 52 Week Low
- MRIN $1.44
- ONVO $0.32
- 52 Week High
- MRIN $5.46
- ONVO $1.74
- Technical
- Relative Strength Index (RSI)
- MRIN 44.99
- ONVO 35.80
- Support Level
- MRIN $1.88
- ONVO $0.42
- Resistance Level
- MRIN $2.03
- ONVO $0.39
- Average True Range (ATR)
- MRIN 0.12
- ONVO 0.05
- MACD
- MRIN -0.02
- ONVO -0.01
- Stochastic Oscillator
- MRIN 33.73
- ONVO 3.38
About MRIN Marin Software Incorporated
Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.